Return On Equity of Intra-Cellular Therapies, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Intra-Cellular Therapies, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Return On Equity for the quarter ending 31 Dec 2024 was -7%, a 68% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Return On Equity for 2024 was -7%, a 68% increase from 2023.
  • Intra-Cellular Therapies, Inc. annual Return On Equity for 2023 was -23%, a 36% increase from 2022.
  • Intra-Cellular Therapies, Inc. annual Return On Equity for 2022 was -36%, a 35% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Intra-Cellular Therapies, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2024 -7% +16% +68% 01 Oct 2024 31 Dec 2024
Q3 2024 -10% +15% +60% 01 Jul 2024 30 Sep 2024
Q2 2024 -11% +17% +60% 01 Apr 2024 30 Jun 2024
Q1 2024 -18% +15% +45% 01 Jan 2024 31 Mar 2024
Q4 2023 -23% +13% +36% 01 Oct 2023 31 Dec 2023
Q3 2023 -25% +21% +45% 01 Jul 2023 30 Sep 2023
Q2 2023 -29% +25% +46% 01 Apr 2023 30 Jun 2023
Q1 2023 -34% +20% +37% 01 Jan 2023 31 Mar 2023
Q4 2022 -36% +19% +35% 01 Oct 2022 31 Dec 2022
Q3 2022 -46% -1% -1.4% 01 Jul 2022 30 Sep 2022
Q2 2022 -53% -16% -42% 01 Apr 2022 30 Jun 2022
Q1 2022 -54% -15% -37% 01 Jan 2022 31 Mar 2022
Q4 2021 -55% -13% -32% 01 Oct 2021 31 Dec 2021
Q3 2021 -45% +3% +7% 01 Jul 2021 30 Sep 2021
Q2 2021 -38% +23% +38% 01 Apr 2021 30 Jun 2021
Q1 2021 -39% +18% +32% 01 Jan 2021 31 Mar 2021
Q4 2020 -42% +19% +32% 01 Oct 2020 31 Dec 2020
Q3 2020 -48% +6% +11% 01 Jul 2020 30 Sep 2020
Q2 2020 -61% -10% -19% 01 Apr 2020 30 Jun 2020
Q1 2020 -58% -12% -26% 01 Jan 2020 31 Mar 2020
Q4 2019 -61% -19% -46% 01 Oct 2019 31 Dec 2019
Q3 2019 -54% -19% -52% 01 Jul 2019 30 Sep 2019
Q2 2019 -51% -19% -60% 01 Apr 2019 30 Jun 2019
Q1 2019 -46% -18% -65% 01 Jan 2019 31 Mar 2019
Q4 2018 -42% -15% -57% 01 Oct 2018 31 Dec 2018
Q3 2018 -36% -8% -30% 01 Jul 2018 30 Sep 2018
Q2 2018 -32% -4% -14% 01 Apr 2018 30 Jun 2018
Q1 2018 -28% +2% +6.9% 01 Jan 2018 31 Mar 2018
Q4 2017 -27% +2% +5.3% 01 Oct 2017 31 Dec 2017
Q3 2017 -27% -1% -2% 01 Jul 2017 30 Sep 2017
Q2 2017 -28% -2% -8.3% 01 Apr 2017 30 Jun 2017
Q1 2017 -30% -3% -10% 01 Jan 2017 31 Mar 2017
Q4 2016 -28% +2% +5.7% 01 Oct 2016 31 Dec 2016
Q3 2016 -27% +8% +23% 01 Jul 2016 30 Sep 2016
Q2 2016 -26% +13% +33% 01 Apr 2016 30 Jun 2016
Q1 2016 -27% +4% +14% 01 Jan 2016 31 Mar 2016
Q4 2015 -30% -7% -30% 01 Oct 2015 31 Dec 2015
Q3 2015 -35% -14% -65% 01 Jul 2015 30 Sep 2015
Q2 2015 -38% -13% -54% 01 Apr 2015 30 Jun 2015
Q1 2015 -31% +17% +35% 01 Jan 2015 31 Mar 2015
Q4 2014 -23% +128% +85% 01 Oct 2014 31 Dec 2014
Q3 2014 -21% 01 Jul 2014 30 Sep 2014
Q2 2014 -25% 01 Apr 2014 30 Jun 2014
Q1 2014 -48% 01 Jan 2014 31 Mar 2014
Q4 2013 -151% 01 Oct 2013 31 Dec 2013

Intra-Cellular Therapies, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -7% +16% +68% 01 Jan 2024 31 Dec 2024
2023 -23% +13% +36% 01 Jan 2023 31 Dec 2023
2022 -36% +19% +35% 01 Jan 2022 31 Dec 2022
2021 -55% -13% -32% 01 Jan 2021 31 Dec 2021
2020 -42% +19% +32% 01 Jan 2020 31 Dec 2020
2019 -61% -19% -46% 01 Jan 2019 31 Dec 2019
2018 -42% -15% -57% 01 Jan 2018 31 Dec 2018
2017 -27% +2% +5.3% 01 Jan 2017 31 Dec 2017
2016 -28% +2% +5.7% 01 Jan 2016 31 Dec 2016
2015 -30% -7% -30% 01 Jan 2015 31 Dec 2015
2014 -23% +128% +85% 01 Jan 2014 31 Dec 2014
2013 -151% 01 Jan 2013 31 Dec 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.